Department of Oncology
Linda M Pilarski has not added Biography.
If you are Linda M Pilarski and would like to personalize this page please email our Author Liaison for assistance.
Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma clone.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2002 | Pubmed ID: 11839670
Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
Experimental hematology Mar, 2002 | Pubmed ID: 11882359
CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.
Journal of immunotherapy (Hagerstown, Md. : 1997) Jan-Feb, 2002 | Pubmed ID: 11924912
Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2002 | Pubmed ID: 12374689
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.
Blood Feb, 2003 | Pubmed ID: 12393535
The malignant clone in Waldenstrom's macroglobulinemia.
Seminars in oncology Apr, 2003 | Pubmed ID: 12720122
Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia.
Seminars in oncology Apr, 2003 | Pubmed ID: 12720129
Improved resolution with microchip-based enhanced field inversion electrophoresis.
Electrophoresis Jun, 2003 | Pubmed ID: 12783455
RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability.
Molecular biology of the cell Jun, 2003 | Pubmed ID: 12808028
Discussion on the safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.
Gastroenterology Nov, 2003 | Pubmed ID: 14628819
Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood.
Blood Oct, 2004 | Pubmed ID: 14764523
Genetics and cytogenetics of multiple myeloma: a workshop report.
Cancer research Feb, 2004 | Pubmed ID: 14989251
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma.
Blood Aug, 2004 | Pubmed ID: 15105292
A combined dielectrophoresis, traveling wave dielectrophoresis and electrorotation microchip for the manipulation and characterization of human malignant cells.
Journal of microbiological methods Sep, 2004 | Pubmed ID: 15279943
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.
Blood May, 2005 | Pubmed ID: 15677557
Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity.
Cancer research Feb, 2005 | Pubmed ID: 15705883
Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer.
Current drug targets. Cardiovascular & haematological disorders Feb, 2005 | Pubmed ID: 15720220
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.
Blood Jun, 2005 | Pubmed ID: 15731173
Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?
Clinical lymphoma Mar, 2005 | Pubmed ID: 15794851
Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia.
Clinical lymphoma Mar, 2005 | Pubmed ID: 15794859
Identification of clonotypic IgH VDJ sequences in multiple myeloma.
Methods in molecular medicine , 2005 | Pubmed ID: 15968099
A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
Medical hypotheses , 2005 | Pubmed ID: 16023302
Sensitive detection using microfluidics technology of single cell PCR products from high and low abundance IgH VDJ templates in multiple myeloma.
Journal of immunological methods Oct, 2005 | Pubmed ID: 16150455
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs.
Journal of immunotherapy (Hagerstown, Md. : 1997) Nov-Dec, 2005 | Pubmed ID: 16224274
Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery.
Blood Apr, 2006 | Pubmed ID: 16317092
Automated screening using microfluidic chip-based PCR and product detection to assess risk of BK virus-associated nephropathy in renal transplant recipients.
Electrophoresis Oct, 2006 | Pubmed ID: 16960845
Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma.
Leukemia & lymphoma Nov, 2006 | Pubmed ID: 17107900
Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2007 | Pubmed ID: 17404080
Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcripts.
The Journal of molecular diagnostics : JMD Jul, 2007 | Pubmed ID: 17591936
Microfluidic platform for single nucleotide polymorphism genotyping of the thiopurine S-methyltransferase gene to evaluate risk for adverse drug events.
The Journal of molecular diagnostics : JMD Sep, 2007 | Pubmed ID: 17690215
Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice.
Experimental hematology Sep, 2007 | Pubmed ID: 17761288
The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma.
British journal of haematology Feb, 2008 | Pubmed ID: 18076711
An inexpensive and portable microchip-based platform for integrated RT-PCR and capillary electrophoresis.
The Analyst Mar, 2008 | Pubmed ID: 18299747
A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma.
Blood Oct, 2008 | Pubmed ID: 18535198
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progeny.
Blood Sep, 2008 | Pubmed ID: 18577707
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.
Blood Dec, 2008 | Pubmed ID: 18815290
Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society Mar, 2009 | Pubmed ID: 19001640
An integrated microfluidic chip for chromosome enumeration using fluorescence in situ hybridization.
Lab on a chip Dec, 2008 | Pubmed ID: 19023479
Strategies for enhancing the speed and integration of microchip genetic amplification.
Electrophoresis Dec, 2008 | Pubmed ID: 19053066
The relationships among physiologic variables, quality of life, and fatigue in patients with multiple myeloma.
Oncology nursing forum Mar, 2009 | Pubmed ID: 19273410
Genetic abnormalities in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma Mar, 2009 | Pubmed ID: 19362966
Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer.
The Journal of biological chemistry Jul, 2009 | Pubmed ID: 19451652
Promiscuity of translocation partners in multiple myeloma.
Journal of cellular biochemistry Apr, 2010 | Pubmed ID: 20127714
Multiple myeloma may include microvessel endothelial cells of malignant origin.
Leukemia & lymphoma Apr, 2010 | Pubmed ID: 20233053
In-gel technology for PCR genotyping and pathogen detection.
Analytical chemistry Oct, 2010 | Pubmed ID: 20809605
In a patient with biclonal Waldenstrom macroglobulinemia only one clone expands in three-dimensional culture and includes putative cancer stem cells.
Leukemia & lymphoma Feb, 2011 | Pubmed ID: 21133724
Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma.
Leukemia research Dec, 2011 | Pubmed ID: 21816470
Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist During Treatment with Rituximab.
Clinical medicine. Oncology , 2008 | Pubmed ID: 21892289
A miniaturized and integrated gel post platform for multiparameter PCR detection of herpes simplex viruses from raw genital swabs.
Lab on a chip May, 2012 | Pubmed ID: 22426784
Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
Genes, chromosomes & cancer Aug, 2012 | Pubmed ID: 22489023
In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival.
American journal of hematology Jun, 2012 | Pubmed ID: 22495885
In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival.
Molecular cancer , 2012 | Pubmed ID: 23083101
Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes.
PloS one , 2013 | Pubmed ID: 23301075
Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
Genes, chromosomes & cancer Jun, 2013 | Pubmed ID: 23460268
An enclosed in-gel PCR amplification cassette with multi-target, multi-sample detection for platform molecular diagnostics.
Lab on a chip Jul, 2013 | Pubmed ID: 23471315
Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets.
Current cancer drug targets May, 2013 | Pubmed ID: 23517594
The systemic cytokine environment is permanently altered in multiple myeloma.
PloS one , 2013 | Pubmed ID: 23544044
Frequent occurrence of highly expanded but unrelated B-cell clones in patients with multiple myeloma.
PloS one , 2013 | Pubmed ID: 23724106
Storing self-contained gel capillary cassettes for POC medical diagnostics.
Lab on a chip Oct, 2013 | Pubmed ID: 23966212
A novel method for sample delivery and testing of whole blood: gel strip PCR for point of care (POC) molecular diagnostics.
Lab on a chip Oct, 2013 | Pubmed ID: 23966268
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유